| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9
|
Khorsand, Behnoush
|
|
2017
|
19 |
2 |
p. 438-446
|
article
|
| 2 |
A Model for Predicting the Interindividual Variability of Drug-Drug Interactions
|
Tod, M.
|
|
2016
|
19 |
2 |
p. 497-509
|
article
|
| 3 |
An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab
|
Passey, Chaitali
|
|
2017
|
19 |
2 |
p. 557-567
|
article
|
| 4 |
Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development
|
Salazar-Fontana, Laura I.
|
|
2017
|
19 |
2 |
p. 377-385
|
article
|
| 5 |
Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products
|
Wang, Rong
|
|
2016
|
19 |
2 |
p. 360-366
|
article
|
| 6 |
Cardiovascular Ion Channel Inhibitor Drug-Drug Interactions with P-glycoprotein
|
Ledwitch, Kaitlyn V.
|
|
2016
|
19 |
2 |
p. 409-420
|
article
|
| 7 |
Clinical Translation of the National Institutes of Health’s Investments in Nanodrug Products and Devices
|
Henderson, Lori A.
|
|
2016
|
19 |
2 |
p. 343-359
|
article
|
| 8 |
Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors
|
Yang, Yang
|
|
2016
|
19 |
2 |
p. 386-396
|
article
|
| 9 |
Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer
|
Yang, Tianzhi
|
|
2016
|
19 |
2 |
p. 475-486
|
article
|
| 10 |
Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells
|
Yang, Yuqing
|
|
2016
|
19 |
2 |
p. 421-430
|
article
|
| 11 |
Erratum to: Intra-articular Injection of Urinary Bladder Matrix Reduces Osteoarthritis Development
|
Jacobs, Heather N.
|
|
2016
|
19 |
2 |
p. 595
|
article
|
| 12 |
Erratum to: Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling
|
Tiwari, Abhinav
|
|
2017
|
19 |
2 |
p. 597
|
article
|
| 13 |
Erratum to: Tumor Static Concentration Curves in Combination Therapy
|
Cardilin, Tim
|
|
2017
|
19 |
2 |
p. 596
|
article
|
| 14 |
Exposure–Response and Tumor Growth Inhibition Analyses of the Monovalent Anti-c-MET Antibody Onartuzumab (MetMAb) in the Second- and Third-Line Non-Small Cell Lung Cancer
|
Han, Kelong
|
|
2016
|
19 |
2 |
p. 527-533
|
article
|
| 15 |
GDF11 Treatment Attenuates the Recovery of Skeletal Muscle Function After Injury in Older Rats
|
Zhou, Yu
|
|
2016
|
19 |
2 |
p. 431-437
|
article
|
| 16 |
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes
|
Carlier, Jeremy
|
|
2017
|
19 |
2 |
p. 568-577
|
article
|
| 17 |
Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure
|
Herskovitz, Jonathan
|
|
2017
|
19 |
2 |
p. 447-455
|
article
|
| 18 |
Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations
|
Siqueira, Scheyla D.V.S.
|
|
2017
|
19 |
2 |
p. 587-594
|
article
|
| 19 |
Insulin Formulation Characterization—the Thioflavin T Assays
|
Schlein, Morten
|
|
2016
|
19 |
2 |
p. 397-408
|
article
|
| 20 |
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling
|
Kratochwil, Nicole A.
|
|
2016
|
19 |
2 |
p. 534-550
|
article
|
| 21 |
Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development
|
Thelin, Eric Peter
|
|
2017
|
19 |
2 |
p. 367-376
|
article
|
| 22 |
Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling
|
Tiwari, Abhinav
|
|
2016
|
19 |
2 |
p. 510-519
|
article
|
| 23 |
Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients
|
Ahmed, Ghada F.
|
|
2017
|
19 |
2 |
p. 551-556
|
article
|
| 24 |
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
|
Cirincione, Brenda
|
|
2016
|
19 |
2 |
p. 487-496
|
article
|
| 25 |
Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles
|
Leung, Sharon Shui Yee
|
|
2017
|
19 |
2 |
p. 578-586
|
article
|
| 26 |
Tissue Concentration of Dodecafluoropentane (DDFP) Following Repeated IV Administration in the New Zealand White Rabbit
|
Arthur, Christine
|
|
2016
|
19 |
2 |
p. 520-526
|
article
|
| 27 |
Tumor Static Concentration Curves in Combination Therapy
|
Cardilin, Tim
|
|
2016
|
19 |
2 |
p. 456-467
|
article
|
| 28 |
Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges
|
Li, Jinjiang
|
|
2016
|
19 |
2 |
p. 321-333
|
article
|
| 29 |
Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization
|
Deitchman, Amelia N.
|
|
2016
|
19 |
2 |
p. 334-342
|
article
|
| 30 |
Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab
|
Bian, Sumin
|
|
2016
|
19 |
2 |
p. 468-474
|
article
|
Journal description